Making sense of differences in pneumococcal serotype replacement
- 29 January 2019
- journal article
- review article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 19 (6), e213-e220
- https://doi.org/10.1016/s1473-3099(18)30660-1
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Allergy and Infectious Diseases, US National Institutes of Health (grant R01AI106786)
This publication has 64 references indexed in Scilit:
- Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance SitesPLoS Medicine, 2013
- Influenza and RSV make a modest contribution to invasive pneumococcal disease incidence in the UKJournal of Infection, 2013
- Serotype replacement in disease after pneumococcal vaccinationThe Lancet, 2011
- Impact of More Than a Decade of Pneumococcal Conjugate Vaccine Use on Carriage and Invasive Potential in Native American CommunitiesThe Journal of Infectious Diseases, 2011
- Effect of Pneumococcal Conjugate Vaccination on Serotype-Specific Carriage and Invasive Disease in England: A Cross-Sectional StudyPLoS Medicine, 2011
- Rapid Pneumococcal Evolution in Response to Clinical InterventionsScience, 2011
- Association of Serotype with Risk of Death Due to Pneumococcal Pneumonia: A Meta‐AnalysisClinical Infectious Diseases, 2010
- Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now completeEpidemics, 2010
- Continued Impact of Pneumococcal Conjugate Vaccine on Carriage in Young ChildrenPEDIATRICS, 2009
- Social Contacts and Mixing Patterns Relevant to the Spread of Infectious DiseasesPLoS Medicine, 2008